25 XP   0   0   10

Amedisys Inc
Buy, Hold or Sell?

Let's analyse Amedisys together

PenkeI guess you are interested in Amedisys Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Amedisys Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Amedisys Inc

I send you an email if I find something interesting about Amedisys Inc.

Quick analysis of Amedisys (30 sec.)










What can you expect buying and holding a share of Amedisys? (30 sec.)

How much money do you get?

How much money do you get?
$0.80
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
$34.28
Expected worth in 1 year
$35.90
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
$2.42
Return On Investment
2.6%

For what price can you sell your share?

Current Price per Share
$91.79
Expected price per share
$85.81 - $94.92
How sure are you?
50%

1. Valuation of Amedisys (5 min.)




Live pricePrice per Share (EOD)

$91.79

Intrinsic Value Per Share

$-29.78 - $55.87

Total Value Per Share

$4.49 - $90.15

2. Growth of Amedisys (5 min.)




Is Amedisys growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$1.1b$13.2m1.2%

How much money is Amedisys making?

Current yearPrevious yearGrowGrow %
Making money-$9.7m$118.6m-$128.3m-1,316.9%
Net Profit Margin-0.4%5.3%--

How much money comes from the company's main activities?

3. Financial Health of Amedisys (5 min.)




4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#26 / 186

Most Revenue
#35 / 186

Most Profit
#89 / 186

Most Efficient
#114 / 186

What can you expect buying and holding a share of Amedisys? (5 min.)

Welcome investor! Amedisys's management wants to use your money to grow the business. In return you get a share of Amedisys.

What can you expect buying and holding a share of Amedisys?

First you should know what it really means to hold a share of Amedisys. And how you can make/lose money.

Speculation

The Price per Share of Amedisys is $91.79. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Amedisys.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Amedisys, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $34.28. Based on the TTM, the Book Value Change Per Share is $0.40 per quarter. Based on the YOY, the Book Value Change Per Share is $4.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.20 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Amedisys.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.30-0.3%-0.30-0.3%3.634.0%3.814.1%2.492.7%
Usd Book Value Change Per Share0.400.4%0.400.4%4.264.6%3.984.3%2.292.5%
Usd Dividend Per Share0.200.2%0.200.2%0.050.1%64.8570.7%45.9450.0%
Usd Total Gains Per Share0.600.7%0.600.7%4.314.7%68.8475.0%48.2252.5%
Usd Price Per Share95.06-95.06-83.54-160.15-108.19-
Price to Earnings Ratio-318.60--318.60-23.01--34.70--39.66-
Price-to-Total Gains Ratio157.32-157.32-19.38-36.45-29.14-
Price to Book Ratio2.77-2.77-2.47-6.27-5.17-
Price-to-Total Gains Ratio157.32-157.32-19.38-36.45-29.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share91.79
Number of shares10
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.2064.85
Usd Book Value Change Per Share0.403.98
Usd Total Gains Per Share0.6068.84
Gains per Quarter (10 shares)6.04688.37
Gains per Year (10 shares)24.172,753.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18161425941592743
216323851883195496
324496277824788249
43265861037763711002
540811101297179713755
648971341556595616508
75611315818159111519261
86412918220753127522014
97214620623347143424767
108016223025941159327520

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%22.08.01.071.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%26.05.00.083.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.01.090.0%13.00.018.041.9%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%27.04.00.087.1%

Fundamentals of Amedisys

About Amedisys Inc

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Fundamental data was last updated by Penke on 2024-04-11 00:26:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Amedisys Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Amedisys earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • A Net Profit Margin of -0.4% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Amedisys Inc:

  • The MRQ is -0.4%. The company is not making a profit/loss.
  • The TTM is -0.4%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ-0.4%TTM-0.4%0.0%
TTM-0.4%YOY5.3%-5.8%
TTM-0.4%5Y5.9%-6.4%
5Y5.9%10Y4.2%+1.7%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.4%2.5%-2.9%
TTM-0.4%2.4%-2.8%
YOY5.3%3.5%+1.8%
5Y5.9%3.1%+2.8%
10Y4.2%3.7%+0.5%
1.1.2. Return on Assets

Shows how efficient Amedisys is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • -0.5% Return on Assets means that Amedisys generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Amedisys Inc:

  • The MRQ is -0.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.5%TTM-0.5%0.0%
TTM-0.5%YOY6.0%-6.5%
TTM-0.5%5Y7.7%-8.2%
5Y7.7%10Y6.5%+1.2%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.5%0.7%-1.2%
TTM-0.5%0.6%-1.1%
YOY6.0%1.1%+4.9%
5Y7.7%0.9%+6.8%
10Y6.5%1.2%+5.3%
1.1.3. Return on Equity

Shows how efficient Amedisys is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • -0.9% Return on Equity means Amedisys generated $-0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Amedisys Inc:

  • The MRQ is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-0.9%0.0%
TTM-0.9%YOY11.3%-12.2%
TTM-0.9%5Y15.1%-16.0%
5Y15.1%10Y11.7%+3.4%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%2.1%-3.0%
TTM-0.9%2.1%-3.0%
YOY11.3%2.8%+8.5%
5Y15.1%2.3%+12.8%
10Y11.7%2.7%+9.0%

1.2. Operating Efficiency of Amedisys Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Amedisys is operating .

  • Measures how much profit Amedisys makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • An Operating Margin of 8.6% means the company generated $0.09  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Amedisys Inc:

  • The MRQ is 8.6%. The company is operating less efficient.
  • The TTM is 8.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ8.6%TTM8.6%0.0%
TTM8.6%YOY8.1%+0.5%
TTM8.6%5Y9.6%-0.9%
5Y9.6%10Y8.0%+1.6%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ8.6%6.7%+1.9%
TTM8.6%6.7%+1.9%
YOY8.1%7.0%+1.1%
5Y9.6%6.4%+3.2%
10Y8.0%8.1%-0.1%
1.2.2. Operating Ratio

Measures how efficient Amedisys is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 0.91 means that the operating costs are $0.91 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Amedisys Inc:

  • The MRQ is 0.914. The company is less efficient in keeping operating costs low.
  • The TTM is 0.914. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.914TTM0.9140.000
TTM0.914YOY0.917-0.004
TTM0.9145Y0.904+0.010
5Y0.90410Y0.924-0.020
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9141.161-0.247
TTM0.9141.105-0.191
YOY0.9171.028-0.111
5Y0.9041.026-0.122
10Y0.9241.004-0.080

1.3. Liquidity of Amedisys Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Amedisys is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 1.05 means the company has $1.05 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Amedisys Inc:

  • The MRQ is 1.049. The company is just able to pay all its short-term debts.
  • The TTM is 1.049. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.049TTM1.0490.000
TTM1.049YOY1.094-0.045
TTM1.0495Y0.992+0.057
5Y0.99210Y1.044-0.051
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0491.285-0.236
TTM1.0491.304-0.255
YOY1.0941.342-0.248
5Y0.9921.385-0.393
10Y1.0441.424-0.380
1.3.2. Quick Ratio

Measures if Amedisys is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • A Quick Ratio of 1.00 means the company can pay off $1.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Amedisys Inc:

  • The MRQ is 1.001. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.001. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.001TTM1.0010.000
TTM1.001YOY0.949+0.052
TTM1.0015Y0.871+0.129
5Y0.87110Y0.925-0.054
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0010.893+0.108
TTM1.0010.946+0.055
YOY0.9491.056-0.107
5Y0.8711.159-0.288
10Y0.9251.146-0.221

1.4. Solvency of Amedisys Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Amedisys assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Amedisys to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.46 means that Amedisys assets are financed with 45.6% credit (debt) and the remaining percentage (100% - 45.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Amedisys Inc:

  • The MRQ is 0.456. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.456. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.456TTM0.4560.000
TTM0.456YOY0.440+0.016
TTM0.4565Y0.469-0.013
5Y0.46910Y0.422+0.047
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4560.518-0.062
TTM0.4560.546-0.090
YOY0.4400.522-0.082
5Y0.4690.564-0.095
10Y0.4220.529-0.107
1.4.2. Debt to Equity Ratio

Measures if Amedisys is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 88.2% means that company has $0.88 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Amedisys Inc:

  • The MRQ is 0.882. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.882. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.882TTM0.8820.000
TTM0.882YOY0.827+0.055
TTM0.8825Y0.912-0.030
5Y0.91210Y0.757+0.155
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8820.912-0.030
TTM0.8820.952-0.070
YOY0.8271.078-0.251
5Y0.9121.231-0.319
10Y0.7571.261-0.504

2. Market Valuation of Amedisys Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Amedisys generates.

  • Above 15 is considered overpriced but always compare Amedisys to the Medical Care Facilities industry mean.
  • A PE ratio of -318.60 means the investor is paying $-318.60 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Amedisys Inc:

  • The EOD is -307.639. Based on the earnings, the company is expensive. -2
  • The MRQ is -318.599. Based on the earnings, the company is expensive. -2
  • The TTM is -318.599. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-307.639MRQ-318.599+10.960
MRQ-318.599TTM-318.5990.000
TTM-318.599YOY23.009-341.608
TTM-318.5995Y-34.699-283.900
5Y-34.69910Y-39.657+4.958
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-307.63911.569-319.208
MRQ-318.59910.707-329.306
TTM-318.59914.196-332.795
YOY23.00911.894+11.115
5Y-34.69917.599-52.298
10Y-39.65720.381-60.038
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Amedisys Inc:

  • The EOD is 24.090. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 24.948. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 24.948. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD24.090MRQ24.948-0.858
MRQ24.948TTM24.9480.000
TTM24.948YOY21.647+3.300
TTM24.9485Y27.734-2.786
5Y27.73410Y20.936+6.798
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD24.0908.673+15.417
MRQ24.9487.539+17.409
TTM24.9487.539+17.409
YOY21.6476.337+15.310
5Y27.7346.951+20.783
10Y20.9365.303+15.633
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Amedisys is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 2.77 means the investor is paying $2.77 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Amedisys Inc:

  • The EOD is 2.678. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.773. Based on the equity, the company is underpriced. +1
  • The TTM is 2.773. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.678MRQ2.773-0.095
MRQ2.773TTM2.7730.000
TTM2.773YOY2.466+0.307
TTM2.7735Y6.265-3.492
5Y6.26510Y5.169+1.097
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD2.6781.858+0.820
MRQ2.7731.861+0.912
TTM2.7731.942+0.831
YOY2.4662.124+0.342
5Y6.2652.374+3.891
10Y5.1692.501+2.668
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Amedisys Inc.

3.1. Institutions holding Amedisys Inc

Institutions are holding 96.173% of the shares of Amedisys Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc9.85250.00673218592-22568-0.6963
2023-12-31BlackRock Inc9.07480.0072296451998910.3348
2023-12-31Fidelity International Ltd3.99580.1304130533313053330
2023-12-31Eckert Corp3.8916.196127109723760022.9899
2023-12-31Millennium Management LLC3.63410.0488118717638041147.1526
2023-12-31State Street Corporation2.85740.004393344363680.6869
2023-12-31Westchester Capital Management LLC2.6922.926879402290163.4121
2023-12-31Mackenzie Investments2.68690.1258877747-63311-6.7276
2023-12-31Park West Asset Management LLC2.48597.5624812069603508.0283
2023-12-31Pentwater Capital Management LP2.38770.8313780000-364000-31.8182
2023-12-31Water Island Capital LLC2.17556.9199710697461368185.0439
2023-12-31Melqart Asset Management (UK) Ltd.2.00154.565265382830350086.6331
2023-12-31Magnetar Financial LLC1.89461.4937618911110511.818
2023-12-31AllianceBernstein L.P.1.66860.01995450795750311.7936
2023-12-31Geode Capital Management, LLC1.61490.0053527548138322.6925
2023-12-31Dimensional Fund Advisors, Inc.1.56620.0142511641-169675-24.904
2023-12-31Cresset Asset Management, LLC1.39090.25814543592700.0595
2023-12-31Van Lanschot Kempen Investment Management NV1.38120.5987451194339558.138
2023-12-31Woodline Partners LP1.36740.4618446693-15613-3.3772
2023-12-31Marshall Wace Asset Management Ltd1.24470.06554066289248529.4404
Total 59.863632.241219555956+2367766+12.1%

3.2. Funds holding Amedisys Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv3.10410.0061101404400
2024-02-29iShares Core S&P Mid-Cap ETF3.0410.1147993423-2135-0.2145
2024-02-29Vanguard Small Cap Index2.57460.055784106677280.9274
2023-12-31The Merger Fund A2.40532.766378575013256320.2948
2023-12-31Fidelity Canadian Large Cap Sr B2.08161.2091680000580000580
2024-02-29Vanguard Small Cap Value Index Inv1.75820.100557434840040.702
2024-01-31Fidelity Canadian Large Cp Mlt Ast Bs O1.53062.068250000000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.46090.043547723345440.9613
2023-12-31Canada Life US Small-Mid Cap Growth A1.37581.908744945700
2024-02-29BlackRock Event Driven Equity Instl1.33940.721143754300
2024-02-29Kempen (Lux) Global Small-Cap I1.18251.955238628200
2023-11-30Arbitrage R1.06043.0806346411236545215.3032
2024-02-29SPDR® S&P MIDCAP 400 ETF Trust0.79780.11532606269660.372
2023-12-31Calamos Market Neutral Income A0.74110.16672421102421100
2023-12-31Janus Henderson Mid Cap Value L0.65541.005214116-10139-4.5212
2023-12-31Fidelity Monthly Income Series F0.62690.363120479610144098.1462
2023-12-31Ranger Small Cap0.60751.306919845511550.5854
2023-12-31Mackenzie US Mid Cap Opportunities F0.60131.468619642800
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.58330.042419053844002.3638
2024-01-31Fidelity Extended Market Index0.55290.047518063116100.8993
Total 28.080618.54529173257+1304791+14.2%

3.3. Insider Transactions

Insiders are holding 2.262% of the shares of Amedisys Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-03-03Michael Paul NorthSELL590886.43
2022-06-23Denise M BohnertSELL557115
2022-03-29David L KemmerlySELL2500177.31
2021-11-30Richard A LechleiterBUY1000141.25
2021-09-01Bruce D. PerkinsSELL11511183
2021-08-02Christopher GerardSELL1250261.24
2021-05-28Scott G. GinnSELL975261.6
2021-05-25Christopher GerardSELL1250259.59
2021-04-09David L. KemmerlySELL500280

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Amedisys Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4040.4040%4.263-91%3.984-90%2.288-82%
Book Value Per Share--34.27834.2780%33.874+1%28.316+21%20.921+64%
Current Ratio--1.0491.0490%1.094-4%0.992+6%1.044+1%
Debt To Asset Ratio--0.4560.4560%0.440+4%0.469-3%0.422+8%
Debt To Equity Ratio--0.8820.8820%0.827+7%0.912-3%0.757+16%
Dividend Per Share--0.2000.2000%0.048+318%64.853-100%45.936-100%
Eps---0.298-0.2980%3.631-108%3.807-108%2.487-112%
Free Cash Flow Per Share--3.8103.8100%3.859-1%5.521-31%3.846-1%
Free Cash Flow To Equity Per Share--1.1111.1110%2.928-62%6.416-83%3.611-69%
Gross Profit Margin--78.35578.3550%1.000+7735%16.471+376%8.735+797%
Intrinsic Value_10Y_max--55.871--------
Intrinsic Value_10Y_min---29.785--------
Intrinsic Value_1Y_max--5.550--------
Intrinsic Value_1Y_min--2.146--------
Intrinsic Value_3Y_max--16.713--------
Intrinsic Value_3Y_min--2.042--------
Intrinsic Value_5Y_max--27.920--------
Intrinsic Value_5Y_min---2.890--------
Market Cap2998559004.000-4%3105382056.0003105382056.0000%2729051304.000+14%5287426792.000-41%3588124943.000-13%
Net Profit Margin---0.004-0.0040%0.053-108%0.059-107%0.042-110%
Operating Margin--0.0860.0860%0.081+6%0.096-10%0.080+8%
Operating Ratio--0.9140.9140%0.9170%0.904+1%0.924-1%
Pb Ratio2.678-4%2.7732.7730%2.466+12%6.265-56%5.169-46%
Pe Ratio-307.639+3%-318.599-318.5990%23.009-1485%-34.699-89%-39.657-88%
Price Per Share91.790-4%95.06095.0600%83.540+14%160.146-41%108.185-12%
Price To Free Cash Flow Ratio24.090-4%24.94824.9480%21.647+15%27.734-10%20.936+19%
Price To Total Gains Ratio151.910-4%157.322157.3220%19.379+712%36.450+332%29.145+440%
Quick Ratio--1.0011.0010%0.949+5%0.871+15%0.925+8%
Return On Assets---0.005-0.0050%0.060-108%0.077-106%0.065-107%
Return On Equity---0.009-0.0090%0.113-108%0.151-106%0.117-108%
Total Gains Per Share--0.6040.6040%4.311-86%68.837-99%48.224-99%
Usd Book Value--1119783000.0001119783000.0000%1106573000.000+1%930986600.000+20%692333200.000+62%
Usd Book Value Change Per Share--0.4040.4040%4.263-91%3.984-90%2.288-82%
Usd Book Value Per Share--34.27834.2780%33.874+1%28.316+21%20.921+64%
Usd Dividend Per Share--0.2000.2000%0.048+318%64.853-100%45.936-100%
Usd Eps---0.298-0.2980%3.631-108%3.807-108%2.487-112%
Usd Free Cash Flow--124475000.000124475000.0000%126068000.000-1%182089400.000-32%127775200.000-3%
Usd Free Cash Flow Per Share--3.8103.8100%3.859-1%5.521-31%3.846-1%
Usd Free Cash Flow To Equity Per Share--1.1111.1110%2.928-62%6.416-83%3.611-69%
Usd Market Cap2998559004.000-4%3105382056.0003105382056.0000%2729051304.000+14%5287426792.000-41%3588124943.000-13%
Usd Price Per Share91.790-4%95.06095.0600%83.540+14%160.146-41%108.185-12%
Usd Profit---9747000.000-9747000.0000%118609000.000-108%125675000.000-108%82503800.000-112%
Usd Revenue--2236382000.0002236382000.0000%2223199000.000+1%2140169000.000+4%1781965200.000+26%
Usd Total Gains Per Share--0.6040.6040%4.311-86%68.837-99%48.224-99%
 EOD+3 -5MRQTTM+0 -0YOY+15 -215Y+14 -2210Y+13 -23

4.2. Fundamental Score

Let's check the fundamental score of Amedisys Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-307.639
Price to Book Ratio (EOD)Between0-12.678
Net Profit Margin (MRQ)Greater than0-0.004
Operating Margin (MRQ)Greater than00.086
Quick Ratio (MRQ)Greater than11.001
Current Ratio (MRQ)Greater than11.049
Debt to Asset Ratio (MRQ)Less than10.456
Debt to Equity Ratio (MRQ)Less than10.882
Return on Equity (MRQ)Greater than0.15-0.009
Return on Assets (MRQ)Greater than0.05-0.005
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Amedisys Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.985
Ma 20Greater thanMa 5091.784
Ma 50Greater thanMa 10092.575
Ma 100Greater thanMa 20093.506
OpenGreater thanClose91.000
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Net Income  126,83356,775183,60825,464209,072-90,463118,609-128,356-9,747



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,060,170
Total Liabilities940,387
Total Stockholder Equity1,066,514
 As reported
Total Liabilities 940,387
Total Stockholder Equity+ 1,066,514
Total Assets = 2,060,170

Assets

Total Assets2,060,170
Total Current Assets496,935
Long-term Assets1,563,235
Total Current Assets
Cash And Cash Equivalents 145,863
Net Receivables 328,173
Other Current Assets 22,899
Total Current Assets  (as reported)496,935
Total Current Assets  (calculated)496,935
+/-0
Long-term Assets
Property Plant Equipment 130,784
Goodwill 1,244,679
Long Term Investments 66,100
Intangible Assets 102,675
Long-term Assets  (as reported)1,563,235
Long-term Assets  (calculated)1,544,238
+/- 18,997

Liabilities & Shareholders' Equity

Total Current Liabilities473,721
Long-term Liabilities466,666
Total Stockholder Equity1,066,514
Total Current Liabilities
Short-term Debt 62,600
Short Long Term Debt 36,314
Accounts payable 28,237
Other Current Liabilities 382,884
Total Current Liabilities  (as reported)473,721
Total Current Liabilities  (calculated)510,035
+/- 36,314
Long-term Liabilities
Long term Debt 361,862
Capital Lease Obligations 89,037
Long-term Liabilities Other 818
Long-term Liabilities  (as reported)466,666
Long-term Liabilities  (calculated)451,717
+/- 14,949
Total Stockholder Equity
Common Stock38
Retained Earnings 747,925
Other Stockholders Equity 318,551
Total Stockholder Equity (as reported)1,066,514
Total Stockholder Equity (calculated)1,066,514
+/-0
Other
Capital Stock38
Cash and Short Term Investments 145,863
Common Stock Shares Outstanding 32,599
Liabilities and Stockholders Equity 2,060,170
Net Debt 341,350
Net Invested Capital 1,464,690
Net Working Capital 23,214
Property Plant and Equipment Gross 368,606
Short Long Term Debt Total 487,213



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-31
> Total Assets 
4,300
6,300
11,500
16,859
22,870
44,428
42,084
41,570
47,640
58,324
92,473
199,733
339,997
463,756
587,111
1,070,194
1,172,351
1,299,825
858,285
730,595
726,406
669,742
685,085
734,029
813,482
717,118
1,262,745
1,567,198
1,856,968
1,976,245
2,060,170
2,060,1701,976,2451,856,9681,567,1981,262,745717,118813,482734,029685,085669,742726,406730,595858,2851,299,8251,172,3511,070,194587,111463,756339,997199,73392,47358,32447,64041,57042,08444,42822,87016,85911,5006,3004,300
   > Total Current Assets 
3,500
4,400
7,600
10,155
14,601
10,335
14,839
17,520
15,049
22,588
49,596
118,890
92,340
179,205
164,513
194,350
218,036
293,930
232,016
205,788
205,279
135,558
175,263
214,910
311,156
224,118
350,554
361,984
356,684
388,961
496,935
496,935388,961356,684361,984350,554224,118311,156214,910175,263135,558205,279205,788232,016293,930218,036194,350164,513179,20592,340118,89049,59622,58815,04917,52014,83910,33514,60110,1557,6004,4003,500
       Cash And Cash Equivalents 
1,100
200
900
1,104
4,070
572
1,425
6,967
3,515
4,861
29,779
89,679
17,231
84,221
56,190
2,847
34,485
120,295
48,004
14,545
17,303
8,032
27,502
30,197
86,363
20,229
30,294
81,808
42,694
40,540
145,863
145,86340,54042,69481,80830,29420,22986,36330,19727,5028,03217,30314,54548,004120,29534,4852,84756,19084,22117,23189,67929,7794,8613,5156,9671,4255724,0701,1049002001,100
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
4,797
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000004,7970000000000000
       Net Receivables 
2,200
3,800
6,100
8,345
9,748
7,456
11,426
9,228
10,468
13,467
15,185
24,478
68,139
74,929
96,309
175,698
150,269
141,549
148,061
171,972
119,533
99,325
125,010
166,056
201,196
188,972
237,596
255,145
274,961
296,785
328,173
328,173296,785274,961255,145237,596188,972201,196166,056125,01099,325119,533171,972148,061141,549150,269175,69896,30974,92968,13924,47815,18513,46710,4689,22811,4267,4569,7488,3456,1003,8002,200
       Inventory 
100
100
200
442
536
1,703
487
414
822
857
1,879
3,377
0
8,930
6,023
8,086
10,279
9,947
11,321
10,631
66,058
8,493
8,110
7,397
7,329
7,568
74,439
11,766
13,431
25,221
0
025,22113,43111,76674,4397,5687,3297,3978,1108,49366,05810,63111,3219,94710,2798,0866,0238,93003,3771,8798578224144871,703536442200100100
       Other Current Assets 
100
300
400
264
247
604
1,182
715
244
3,403
2,753
1,356
6,970
11,125
5,991
7,719
23,003
22,139
24,630
8,640
2,385
19,708
14,641
11,260
16,268
7,349
8,225
13,265
25,598
26,415
22,899
22,89926,41525,59813,2658,2257,34916,26811,26014,64119,7082,3858,64024,63022,13923,0037,7195,99111,1256,9701,3562,7533,4032447151,182604247264400300100
   > Long-term Assets 
800
1,900
3,900
6,704
8,269
34,093
27,245
24,050
32,591
35,736
42,877
80,843
247,657
284,551
422,598
875,844
954,315
1,005,895
626,269
524,894
521,228
671,639
552,517
556,118
533,448
522,449
912,191
1,205,214
1,500,284
1,587,284
1,563,235
1,563,2351,587,2841,500,2841,205,214912,191522,449533,448556,118552,517671,639521,228524,894626,2691,005,895954,315875,844422,598284,551247,65780,84342,87735,73632,59124,05027,24534,0938,2696,7043,9001,900800
       Property Plant Equipment 
400
1,100
2,400
4,610
4,785
8,574
3,439
2,935
10,290
8,257
7,219
10,003
27,389
52,960
68,313
79,258
91,919
138,554
148,536
156,746
159,109
274,910
85,390
73,998
62,244
58,898
112,904
117,159
119,692
118,882
130,784
130,784118,882119,692117,159112,90458,89862,24473,99885,390274,910159,109156,746148,536138,55491,91979,25868,31352,96027,38910,0037,2198,25710,2902,9353,4398,5744,7854,6102,4001,100400
       Goodwill 
0
0
0
0
0
0
0
0
22,216
25,768
35,658
62,537
197,002
213,032
332,534
733,881
786,923
791,412
334,695
209,594
208,915
205,587
261,663
288,957
319,949
329,480
658,500
932,685
1,196,090
1,287,399
1,244,679
1,244,6791,287,3991,196,090932,685658,500329,480319,949288,957261,663205,587208,915209,594334,695791,412786,923733,881332,534213,032197,00262,53735,65825,76822,21600000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,702
27,800
26,400
35,100
35,700
14,200
53,100
60,500
66,100
66,10060,50053,10014,20035,70035,10026,40027,80025,7020000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
22,216
25,623
35,658
66,984
208,449
12,733
14,301
42,388
57,608
53,393
50,067
47,050
36,690
33,193
44,047
46,755
46,061
44,132
64,748
74,183
111,190
101,167
102,675
102,675101,167111,19074,18364,74844,13246,06146,75544,04733,19336,69047,05050,06753,39357,60842,38814,30112,733208,44966,98435,65825,62322,21600000000
       Long-term Assets Other 
400
800
1,500
1,000
1,907
24,830
23,806
21,115
22,301
25,768
7,212
3,856
11,819
5,826
7,450
20,317
17,865
22,536
24,322
12,100
9,400
9,361
10,472
10,668
22,730
19,045
18,912
19,000
19,923
-20,391,664
-35,238
-35,238-20,391,66419,92319,00018,91219,04522,73010,66810,4729,3619,40012,10024,32222,53617,86520,3177,4505,82611,8193,8567,21225,76822,30121,11523,80624,8301,9071,0001,500800400
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,649
92,804
90,214
124,788
125,245
107,940
0
0
0
0
0
0
0
0000000107,940125,245124,78890,21492,80468,649000000000000000000
> Total Liabilities 
2,400
4,100
7,200
12,356
14,590
56,009
52,188
43,490
44,266
41,361
41,074
51,260
147,398
99,749
139,291
508,076
436,016
420,110
338,137
276,362
353,927
271,980
274,649
272,887
297,056
234,485
621,232
756,457
880,645
869,672
940,387
940,387869,672880,645756,457621,232234,485297,056272,887274,649271,980353,927276,362338,137420,110436,016508,076139,29199,749147,39851,26041,07441,36144,26643,49052,18856,00914,59012,3567,2004,1002,400
   > Total Current Liabilities 
2,300
3,600
5,800
9,133
11,464
41,615
41,668
22,389
33,409
31,120
34,018
41,976
99,955
81,918
101,736
204,627
229,306
216,304
221,734
204,787
312,416
162,323
175,193
181,348
215,062
222,476
326,943
456,337
374,282
355,529
473,721
473,721355,529374,282456,337326,943222,476215,062181,348175,193162,323312,416204,787221,734216,304229,306204,627101,73681,91899,95541,97634,01831,12033,40922,38941,66841,61511,4649,1335,8003,6002,300
       Short-term Debt 
1,500
2,500
3,100
5,158
6,733
22,120
23,115
6,726
17,051
6,379
5,191
2,112
20,695
3,223
11,049
42,632
44,254
37,178
33,888
37,007
15,704
12,000
5,000
5,220
10,638
1,612
37,696
40,542
44,228
49,017
62,600
62,60049,01744,22840,54237,6961,61210,6385,2205,00012,00015,70437,00733,88837,17844,25442,63211,0493,22320,6952,1125,1916,37917,0516,72623,11522,1206,7335,1583,1002,5001,500
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,000
5,220
10,638
1,612
8,227
10,496
12,995
15,496
36,314
36,31415,49612,99510,4968,2271,61210,6385,2205,0000000000000000000000000
       Accounts payable 
300
400
400
1,416
1,338
7,295
4,739
1,590
2,440
2,495
3,340
6,681
29,922
14,339
14,438
18,652
16,535
23,374
25,475
29,175
20,139
16,056
25,682
30,358
25,384
28,531
31,259
42,674
38,217
43,735
28,237
28,23743,73538,21742,67431,25928,53125,38430,35825,68216,05620,13929,17525,47523,37416,53518,65214,43814,33929,9226,6813,3402,4952,4401,5904,7397,2951,3381,416400400300
       Other Current Liabilities 
500
700
2,300
1,615
3,585
2,119
2,925
11,954
13,918
8,948
9,347
33,183
49,338
6,139
2,811
143,343
168,517
155,752
162,371
-45
-3,928
-471
-735
-310
4
-2,925
-3,089
313,121
-3,364
-20,148,223
382,884
382,884-20,148,223-3,364313,121-3,089-2,9254-310-735-471-3,928-45162,371155,752168,517143,3432,8116,13949,33833,1839,3478,94813,91811,9542,9252,1193,5851,6152,300700500
   > Long-term Liabilities 
200
500
1,500
3,223
3,126
14,394
10,520
21,101
10,857
10,241
7,056
9,284
47,443
17,831
37,555
303,449
206,710
203,806
116,403
71,575
41,511
109,657
99,456
91,539
81,994
12,009
294,289
300,120
506,363
514,143
466,666
466,666514,143506,363300,120294,28912,00981,99491,53999,456109,65741,51171,575116,403203,806206,710303,44937,55517,83147,4439,2847,05610,24110,85721,10110,52014,3943,1263,2231,500500200
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
170,899
144,688
111,551
66,904
33,000
104,372
95,000
87,809
78,203
5,800
232,256
204,511
432,075
419,420
0
0419,420432,075204,511232,2565,80078,20387,80995,000104,37233,00066,904111,551144,688170,8990000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,649
92,804
90,214
124,788
125,245
107,940
0
0
0
0
0
0
0
0000000107,940125,245124,78890,21492,80468,649000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
11,729
2,057
4,725
1,213
826
824
4,936
6,069
5,959
6,412
6,832
4,852
4,671
8,511
5,285
4,456
3,730
3,791
6,234
5,905
33,622
4,979
25,219
0
025,2194,97933,6225,9056,2343,7913,7304,4565,2858,5114,6714,8526,8326,4125,9596,0694,9368248261,2134,7252,05711,7290000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29,399
52,286
0
0
0
0
0
0
0
0
0
0
0
20,411
0
020,4110000000000052,28629,3990000000000000000
> Total Stockholder Equity
1,900
2,200
4,300
4,315
8,274
-11,684
-10,185
-1,920
3,309
16,963
51,399
148,473
192,599
364,007
446,971
561,335
735,166
877,857
518,868
452,340
372,201
397,167
409,568
460,203
515,321
481,582
640,450
809,224
931,351
1,051,573
1,066,514
1,066,5141,051,573931,351809,224640,450481,582515,321460,203409,568397,167372,201452,340518,868877,857735,166561,335446,971364,007192,599148,47351,39916,9633,309-1,920-10,185-11,6848,2744,3154,3002,2001,900
   Common Stock
0
0
0
3
3
3
3
5
7
9
12
15
16
26
26
27
28
29
30
32
33
35
35
35
35
36
37
38
38
38
38
3838383837363535353533323029282726261615129753333000
   Retained Earnings 
600
600
2,400
2,397
1,203
-23,668
-22,368
-15,998
-13,212
-12,460
-4,053
16,451
46,552
84,807
149,570
236,252
372,089
484,669
102,205
18,617
-77,561
-64,785
-67,806
-30,545
204
119,550
246,383
429,991
639,063
757,672
747,925
747,925757,672639,063429,991246,383119,550204-30,545-67,806-64,785-77,56118,617102,205484,669372,089236,252149,57084,80746,55216,451-4,053-12,460-13,212-15,998-22,368-23,6681,2032,3972,400600600
   Accumulated Other Comprehensive Income 
-400
-600
-1,200
0
-4
-104
-5,165
-4,682
-5,065
-6,992
-9,999
-12,682
-628
-22,042
10
-447
114
25
13
15
15
15
15
15
15
15
15
0
0
0
0
000015151515151515151325114-44710-22,042-628-12,682-9,999-6,992-5,065-4,682-5,165-104-40-1,200-600-400
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
363,670
407,156
432,390
450,792
467,890
481,762
504,290
537,472
568,780
603,666
645,256
698,287
728,118
755,063
0
0755,063728,118698,287645,256603,666568,780537,472504,290481,762467,890450,792432,390407,156363,6700000000000000000
   Treasury Stock0-461,200-435,868-319,092-251,241-241,685-53,713-46,774-26,966-19,860-18,176-17,116-15,770-14,022-735-617-437-379-25-25-25-25-25-250000000
   Other Stockholders Equity 
1,700
2,200
3,100
1,915
7,071
12,084
17,344
18,754
21,644
36,406
65,439
144,689
146,659
301,216
297,365
325,503
362,935
393,134
416,620
433,676
449,714
461,902
477,324
490,698
515,067
361,981
394,015
379,195
292,250
293,863
318,551
318,551293,863292,250379,195394,015361,981515,067490,698477,324461,902449,714433,676416,620393,134362,935325,503297,365301,216146,659144,68965,43936,40621,64418,75417,34412,0847,0711,9153,1002,2001,700



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,236,382
Cost of Revenue-1,779,305
Gross Profit457,077457,077
 
Operating Income (+$)
Gross Profit457,077
Operating Expense-264,011
Operating Income193,066193,066
 
Operating Expense (+$)
Research Development0
Selling General Administrative780,060
Selling And Marketing Expenses753,978
Operating Expense264,0111,534,038
 
Net Interest Income (+$)
Interest Income2,522
Interest Expense-31,274
Other Finance Cost-2,453
Net Interest Income-26,299
 
Pretax Income (+$)
Operating Income193,066
Net Interest Income-26,299
Other Non-Operating Income Expenses0
Income Before Tax (EBT)39,623346,509
EBIT - interestExpense = 161,792
40,812
21,527
Interest Expense31,274
Earnings Before Interest and Taxes (EBIT)193,06670,897
Earnings Before Interest and Taxes (EBITDA)216,913
 
After tax Income (+$)
Income Before Tax39,623
Tax Provision-50,171
Net Income From Continuing Ops1,590-10,548
Net Income-9,747
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,043,316
Total Other Income/Expenses Net-153,44326,299
 

Technical Analysis of Amedisys
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Amedisys. The general trend of Amedisys is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Amedisys's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Amedisys Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 93.17 < 93.92 < 94.92.

The bearish price targets are: 90.10 > 89.65 > 85.81.

Tweet this
Amedisys Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Amedisys Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Amedisys Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Amedisys Inc. The current macd is -0.42569606.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Amedisys price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Amedisys. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Amedisys price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Amedisys Inc Daily Moving Average Convergence/Divergence (MACD) ChartAmedisys Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Amedisys Inc. The current adx is 28.67.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Amedisys shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Amedisys Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Amedisys Inc. The current sar is 92.84.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Amedisys Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Amedisys Inc. The current rsi is 48.99. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Amedisys Inc Daily Relative Strength Index (RSI) ChartAmedisys Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Amedisys Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Amedisys price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Amedisys Inc Daily Stochastic Oscillator ChartAmedisys Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Amedisys Inc. The current cci is -25.40178959.

Amedisys Inc Daily Commodity Channel Index (CCI) ChartAmedisys Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Amedisys Inc. The current cmo is 9.25186286.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Amedisys Inc Daily Chande Momentum Oscillator (CMO) ChartAmedisys Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Amedisys Inc. The current willr is -47.42268041.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Amedisys is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Amedisys Inc Daily Williams %R ChartAmedisys Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Amedisys Inc.

Amedisys Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Amedisys Inc. The current atr is 0.87136609.

Amedisys Inc Daily Average True Range (ATR) ChartAmedisys Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Amedisys Inc. The current obv is -3,369,410.

Amedisys Inc Daily On-Balance Volume (OBV) ChartAmedisys Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Amedisys Inc. The current mfi is 26.34.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Amedisys Inc Daily Money Flow Index (MFI) ChartAmedisys Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Amedisys Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Amedisys Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Amedisys Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.985
Ma 20Greater thanMa 5091.784
Ma 50Greater thanMa 10092.575
Ma 100Greater thanMa 20093.506
OpenGreater thanClose91.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Amedisys with someone you think should read this too:
  • Are you bullish or bearish on Amedisys? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Amedisys? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Amedisys Inc

I send you an email if I find something interesting about Amedisys Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Amedisys Inc.

Receive notifications about Amedisys Inc in your mailbox!